BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value: $10.24B (100.0% shares, 0.0% debt)

Holdings (7)

— DIVERSEY HLDGS LTD 41.3%

Value $4.233B Shares 236,350,134 Share Price $17.91 Est. Cost/Share — Unrealized @ Report Date —

SGRY SURGERY PARTNERS INC 31.9%

Value $3.269B Shares 49,064,576 Share Price $66.62 Est. Cost/Share — Unrealized @ Report Date —

— CEREVEL THERAPEUTICS HLDNG, INC. 15.2%

Value $1.553B Shares 60,632,356 Share Price $25.62 Est. Cost/Share — Unrealized @ Report Date —

AVAH AVEANNA HEALTHCARE HLDGS INC 9.8%

Value $1.002B Shares 81,029,675 Share Price $12.37 Est. Cost/Share — Unrealized @ Report Date —

IQV IQVIA HLDGS INC 1.5%

Value $150M Shares 617,484 Share Price $242.32 Est. Cost/Share — Unrealized @ Report Date —

ADV ADVANTAGE SOLUTIONS INC 0.3%

Value $31.18M Shares 2,890,000 Share Price $10.79 Est. Cost/Share — Unrealized @ Report Date —

ATTOF ATENTO S A 0.0%

Value $4.015M Shares 156,574 Share Price $25.64 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	DIVERSEY HLDGS LTD	236,350,134	$4.233B	41.3%	$17.91	—	—	ORD SHS	G28923103
SGRY	SURGERY PARTNERS INC	49,064,576	$3.269B	31.9%	$66.62	—	—	COM	86881A100
—	CEREVEL THERAPEUTICS HLDNG, INC.	60,632,356	$1.553B	15.2%	$25.62	—	—	COM	15678U128
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,029,675	$1.002B	9.8%	$12.37	—	—	COM	05356F105
IQV	IQVIA HLDGS INC	617,484	$150M	1.5%	$242.32	—	—	COM	46266C105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$31.18M	0.3%	$10.79	—	—	COM CL A	00791N102
ATTOF	ATENTO S A	156,574	$4.015M	0.0%	$25.64	—	—	SHS	L0427L204